K-pop

Kwon Eun-bi Releases New Song After 1 Year and 4 Months… Makes Comeback Today with “Déjà Vu”

First New Album with New Agency RBW

KIM HYUNSIK
2026-09-03 16:52:55
[Edaily Starin KIM HYUNSIK Reporter] Singer Kwon Eun-bi is making a comeback on the 3rd with her new song “Déjà Vu” (DEJAVU).
(Photo = RBW)
Kwon Eun-bi will release a single featuring “DEJAVU” at 6 p.m. today via various online music platforms.
“DEJAVU” is a refreshing disco-pop track. The lyrics explore the strange yet familiar attraction and the pleasant flutter of excitement that comes from feeling as though you’ve known someone for a long time, even though you’ve just met.
Kwon Eun-bi transitioned to a solo career in 2021 after previously being a member of the girl groups YeA and IZ*ONE. This marks her first new release in one year and four months since she released the single “Hello Stranger” last April.
“Déjà Vu” holds special significance as it is the first new release from Kwon Eun-bi since she joined RBW.
RBW stated, “Kwon Eun-bi, who has showcased a variety of music and concepts over the years, will continue the artistic direction she has cultivated so far through ‘Déjà Vu’ while taking the first step into a new chapter.”

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02